Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct 29;8(8):102612.
doi: 10.1016/j.rpth.2024.102612. eCollection 2024 Nov.

Hemostatic conditions following autologous transfusion of fresh vs stored platelets in experimental endotoxemia: an open-label randomized controlled trial with healthy volunteers

Affiliations

Hemostatic conditions following autologous transfusion of fresh vs stored platelets in experimental endotoxemia: an open-label randomized controlled trial with healthy volunteers

Stefan F van Wonderen et al. Res Pract Thromb Haemost. .

Abstract

Background: Platelet increment is reportedly lower for maximum stored platelet concentrates (PCs) and during pyrexia, and in vitro function differs between fresh and stored PCs. However, little is known about the function of fresh and stored platelets during inflammation.

Objectives: The aim was to study differences in hemostatic function after transfusion of fresh or stored PCs in a human model of experimental endotoxemia.

Methods: Thirty-six healthy male subjects received either 2 ng/kg lipopolysaccharide (LPS) or a control (physiological saline 0.9%) and were randomly assigned to subsequently receive an autologous transfusion of either fresh (2-days-old) or stored (7-days-old) platelets, or saline control. Extracellular vesicles (EVs) were determined using flow cytometry, thrombin-antithrombin complex (TATc) was assessed using enzyme-linked immunosorbent assay, and hemostatic function was assessed using rotational thromboelastometry (ROTEM).

Results: LPS infusion caused a marked increase in TATc, EVs and fibrinolysis. Thromboelastometry data revealed that following infusion of LPS, subjects exhibited in general a hypocoagulable state compared with those not receiving LPS. Platelet transfusions led to a reduced clotting time and an augmentation in clot strength, indicated by maximum clot firmness, solely among subjects undergoing endotoxemia. There were no significant differences in TATc or amount of EVs release after transfusion of fresh or stored platelets.

Conclusion: A significant increase in TATc and EVs as well as a difference in hemostatic function after endotoxemia were observed. During endotoxemia, platelet transfusion resulted in enhanced coagulation and hemostatic function; however, no substantial differences were observed between transfusion of fresh or stored PCs.

Keywords: endotoxemia; hemostasis; platelet; platelet transfusion; thromboelastography.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Platelet count and thrombin–antithrombin (TATc) levels Δ and over time. Platelet count measurements at different time points during the experiment, showing a decrease 2 hours after infusion of lipopolysaccharide (LPS). There is an increase 2 hours after autologous platelet transfusion of both fresh and stored platelets in the control group. TATc levels increase after LPS infusion, whereas TATc levels remained stable in the control group. Data were analyzed with Student’s t-test or Wilcoxon signed rank test as appropriate and analysis of variance repeated measurements, with main effects for intervention and time, and an interaction effect: ∗P < .05; ∗∗P < .01; ∗∗∗P < .0001. Lipopolysaccharide (2 ng/kg) was administered immediately after time point 0 hours, and the transfusion was administered immediately after time point 2 hours.
Figure 2
Figure 2
Circulating levels of extracellular vesicles (EVs) Δ and over time. Extracellular vesicles increased after lipopolysaccharide (LPS) infusion but not after infusion of the control. Extracellular vesicles were analyzed with Student’s t-test or Wilcoxon signed rank test as appropriate and analysis of variance repeated measurements, with main effects for intervention and time, and an interaction effect: ∗P < .05; ∗∗P < .01; ∗∗∗P < .0001. Lipopolysaccharide (2 ng/kg) was administered immediately after time point 0 hours, and the transfusion was administered immediately after time point 2 hours.
Figure 3
Figure 3
EXTEM rotational thromboelastometry measurements Δ and over time. EXTEM thromboelastometry was analyzed with Student’s t-test or Wilcoxon signed rank test as appropriate and analysis of variance repeated measurements, with main effects for intervention and time, and an interaction effect: ∗P < .05; ∗∗P < .01; ∗∗∗P < .0001. Normal reference values are indicated with horizontal striped lines. Lipopolysaccharide (LPS; 2 ng/kg) was administered immediately after time point 0 hours, and the transfusion was administered immediately after time point 2 hours. A10, amplitude after 10 minutes.
Figure 4
Figure 4
INTEM rotational thromboelastometry measurements Δ and over time. INTEM thromboelastometry data were analyzed with Student’s t-test or Wilcoxon signed rank test as appropriate and analysis of variance repeated measurements, with main effects for intervention and time, and an interaction effect: ∗P < .05; ∗∗P < .01; ∗∗∗P < .0001. Normal reference values are indicated with horizontal striped lines. Lipopolysaccharide (LPS; 2 ng/kg) was administered immediately after time point 0 hours, and the transfusion was administered immediately after time point 2 hours. A10, amplitude after 10 minutes.
Figure 5
Figure 5
FIBTEM rotational thromboelastometry measurements Δ and over time. FIBTEM thromboelastometry data were analyzed with Student’s t-test or Wilcoxon signed rank test as appropriate and analysis of variance repeated measurements, with main effects for intervention and time, and an interaction effect: ∗P < .05; ∗∗P < .01; ∗∗∗P < .0001. Normal reference values are indicated with horizontal striped lines. Lipopolysaccharide (LPS; 2 ng/kg) was administered immediately after time point 0 hours, and the transfusion was administered immediately after time point 2 hours. A10, amplitude after 10 minutes.

Similar articles

References

    1. Yuan S., Otrock Z.K. Platelet transfusion: an update on indications and guidelines. Clin Lab Med. 2021;41:621–634. - PubMed
    1. Stanworth S.J., Shah A. How I use platelet transfusions. Blood. 2022;140:1925–1936. - PubMed
    1. Davis K.B., Slichter S.J., Corash L. Corrected count increment and percent platelet recovery as measures of posttransfusion platelet response: problems and a solution. Transfusion. 1999;39:586–592. - PubMed
    1. Jaime-Pérez J.C., Vázquez-Hernández K.E., Jiménez-Castillo R.A., Fernández L.T., Salazar-Riojas R., Gómez-Almaguer D. Platelet survival in hematology patients assessed by the corrected count increment and other formulas. Am J Clin Pathol. 2018;150:267–272. - PubMed
    1. Slichter S.J., Davis K., Enright H., Braine H., Gernsheimer T., Kao K.J., et al. Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients. Blood. 2005;105:4106–4114. - PMC - PubMed

LinkOut - more resources